Does ABIRATERONE Cause Hepatic encephalopathy? 7 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hepatic encephalopathy have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 0.0% of all adverse event reports for ABIRATERONE.
7
Reports of Hepatic encephalopathy with ABIRATERONE
0.0%
of all ABIRATERONE reports
3
Deaths
7
Hospitalizations
How Dangerous Is Hepatic encephalopathy From ABIRATERONE?
Of the 7 reports, 3 (42.9%) resulted in death, 7 (100.0%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Hepatic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Therapy cessation (1,602)
Prostatic specific antigen increased (1,581)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
What Other Drugs Cause Hepatic encephalopathy?
ACETAMINOPHEN (562)
RIBAVIRIN (512)
LENVATINIB (502)
RIFAXIMIN (462)
SOFOSBUVIR (360)
BEVACIZUMAB (210)
LEDIPASVIR\SOFOSBUVIR (180)
ATEZOLIZUMAB (178)
SORAFENIB (169)
DACLATASVIR (165)
Which ABIRATERONE Alternatives Have Lower Hepatic encephalopathy Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB